AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$23.97
0.42 (1.78%)
▲
5d:
+5.78%
30d:
+17.38%
90d:
-29.83%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: AORT shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.05
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $23.97, which is considered extended relative to its 30-day fair value range of $20.41 to $22.75. From a valuation perspective, the stock is trading at a discount (Forward PE: 33.3) compared to its historical average (37.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. The price is approaching resistance at $24.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+75.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AORT is in a strong downtrend. The price is approaching resistance at $24.15. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: AORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+75.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$20.41 -
$22.75
Company Quality Score
53/100
(HOLD)
Options IV Signal
32th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.4% above its trading range)
- NEUTRAL: Options fairly priced (IV 32th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 75.2% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$20.41 -
$22.75
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$2.99
(12.5%)
Support & Resistance Levels
Support Level
$20.09
Resistance Level
$24.15
Current Trend
Strong Downtrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.29
Wall Street Target
$42.00
(+75.2%)
Revenue Growth (YoY)
17.5%
Profit Margin
2.5%
Valuation Discount vs History
-4.2% cheaper
PE vs Historical
33.3 vs 37.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.2%
(market-implied from PE analysis)
1-Year Target
$22.96
(-4%)
2-Year Target
$22.00
(-8%)
3-Year Target
$21.07
(-12%)
3-Yr Target (if PE normalizes)
(PE: 33→38)
$23.93
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.3, Growth: 63.0%)
$80.90
(+238%)
Base:
(SPY PE: 21.8, Growth: 63.0%)
$52.93
(+121%)
Bear:
(PE: 18.5, Growth: 63.0%)
$44.99
(+88%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (95x PE), but valuation improves significantly next year (33x PE) as earnings recover.
Trailing PE: 94.80 | Current EPS (TTM): $0.25
Bull Case
$52.14
(+118%)
Analyst growth 100.0%, PE expands to 104.3
Base Case
$47.40
(+98%)
Market implied 100.0%, PE stable at 94.8
Bear Case
$16.12
(-33%)
Severe decline -20.0%, PE contracts to 80.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 33.3 to 37.8
Stabilization Target:
$27.22
(+13.5%)
PE Expansion Potential:
+13.5%
Share & Embed Analysis
Last updated: July 04, 2026 3:35 PM ET
Data refreshes hourly during market hours. Next update: 4:35 PM
Data refreshes hourly during market hours. Next update: 4:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 65 BUY |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
